Strength

規(guī)格

100mg, 200mg, 400mg

Product License

ANDA #216235

Indications

適應(yīng)癥

Epilepsy:

①Partial seizures with complex symptomatology   (psychomotor, temporal lobe).

②Generalized tonic-clonic seizures (grand mal).

③Mixed seizure, or other partial or generalized   seizures.

Trigeminal Neuralgia

indicated in the treatment of   the pain associated with true trigeminal neuralgia. Beneficial in   glossopharyngeal neuralgia.

癲癇：

①癥狀復(fù)雜的部分性癲癇發(fā)作（精神運(yùn)動(dòng)、顳葉）②全身強(qiáng)直陣攣性癲癇發(fā)作（大發(fā)作）③混合性癲癇發(fā)作，或其他部分或全身性癲癇發(fā)作

三叉神經(jīng)痛：

用于治療與真正相關(guān)的疼痛，在舌咽神經(jīng)痛方面也有益。

Approved Date

批準(zhǔn)日期

3/02/2023

Market Authorization Holder

持有人

Sciecure Pharma Inc.

Manufacture

生產(chǎn)商

Beijing Sciecure Pharmaceutical Co., Ltd.

北京世橋生物制藥有限公司